Udvalget for Humanmedicinske Lægemidler (CHMP) besluttede, at fordelene ved Vivanza er større end risiciene ved behandling af erektil dysfunktion hos mænd.
The Committee for Medicinal Products for Human Use (CHMP) decided that Vivanza’ s benefits are greater than its risks for the treatment of men with erectile dysfunction.